High Dose Oral Rifampicin to Improve Survival From Adult Tuberculous Meningitis: A Randomised Placebo-Controlled Double-Blinded Phase III Trial (The HARVEST Study)
Wellcome Open Research - United Kingdom
doi 10.12688/wellcomeopenres.15565.1
Full Text
Open PDFAbstract
Available in full text
Date
December 2, 2019
Authors
Publisher
F1000 Research Ltd